Dr. Christopher J Dougherty Ph.D.

View Title...

OncoMune LLC
Hollywood, FL

Christopher's profile was created using:

Sort By:

www.biospace.com/news_story.aspx?NewsEntityId=101475&So - [Cached Version]
Published on: 6/25/2008 Last Visited: 6/25/2008
MIAMI, FL--(Marketwire - June 25, 2008) - OncoMune, a leader in targeted cancer therapeutics, today announced the appointment of Dr. Christopher J. Dougherty, Ph.D., Research Professor at Florida Atlantic University (FAU), as Chief Scientific Officer.
www.genengnews.com/news/bnitem.aspx?name=31442740&nc=1 - [Cached Version]
Published on: 3/3/2008 Last Visited: 3/9/2008
The results will be presented at the upcoming American Association of Cancer Researchers (AACR) Annual Meeting in San Diego, April 12-16 by Dr. Christopher Dougherty, Research Assistant Professor of Biomedical Science at Florida Atlantic University in collaboration with OncoMune.
...
The current data provides validation at the molecular level that BORIS is not only a marker of cancer cells, but is functionally critical for tumor cell survival," Dr. Dougherty said.